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UCP1 is an essential mediator of the effects of
methionine restriction on energy balance but
not insulin sensitivity
Desiree Wanders,* David H. Burk,† Cory C. Cortez,* Nancy T. Van,* Kirsten P. Stone,*
Mollye Baker,* Tamra Mendoza,‡ Randall L. Mynatt,‡ and Thomas W. Gettys*,1
*Laboratory of Nutrient Sensing and Adipocyte Signaling, †Cell Biology and Bioimaging Core,
and ‡Gene Nutrient Interactions; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
ABSTRACT Dietary methionine restriction (MR) by
80% increases energy expenditure (EE), reducesadiposity,
and improves insulin sensitivity. We propose that the MR-
induced increase in EE limits fat deposition by increasing
sympathetic nervous system–dependent remodeling of
white adipose tissue and increasing uncoupling protein 1
(UCP1)expression inbothwhite andbrownadipose tissue.
In independent assessments of the role of UCP1 as a me-
diator ofMR’s effects on EE and insulin sensitivity, EE did
not differ between wild-type (WT) and Ucp12/2 mice on
the control diet, butMR increasedEEby 31% and reduced
adiposity by 25% in WT mice. In contrast, MR failed to
increase EE or reduce adiposity in Ucp12/2 mice. How-
ever, MR was able to increase overall insulin sensitivity by
2.2-fold in both genotypes. Housing temperatures used to
minimize (28°C) or increase (23°C) sympathetic nervous
system activity revealed temperature-independent effects
of the diet on EE. Metabolomics analysis showed that ge-
notypic and dietary effects on white adipose tissue
remodeling resulted in profound increases in fatty acid
metabolism within this tissue. These findings establish that
UCP1 is required for the MR-induced increase in EE but
not insulin sensitivity and suggest that diet-induced
improvements in insulin sensitivity are not strictly derived
from dietary effects on energy balance.—Wanders, D.,
Burk, D. H., Cortez, C. C., Van, N. T., Stone, K. P., Baker,
M., Mendoza, T., Mynatt, R. L., Gettys, T. W. UCP1 is an
essential mediator of the effects of methionine restriction
on energy balance but not insulin sensitivity. FASEB J.
29, 2603–2615 (2015). www.fasebj.org
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DIETARY METHIONINE RESTRICTION (MR) produces an in-
tegrated series ofmetabolic and physiologic responses that
developquickly after introduction of the diet andmaintain
the improvements in biomarkers ofmetabolic health for as
long as the diet is consumed (1–3). The most prominent
physiologic responses are coordinated increases in energy
intake and expenditure (2), with the larger effect on en-
ergy expenditure (EE) limiting ongoing fat deposition by
increasing the proportion of total energy intake required
for maintenance of existing tissue. When the decrease in
net energy available for growth is integrated over time, it
significantly limits the normal age-associated expansion of
adipose tissue (4, 5). The diet also increases in vivo insulin
sensitivity through a combination of direct and indirect
effects of MR on liver, adipose tissue, and muscle (6).
These mechanisms notwithstanding, improvements in
overall insulin sensitivity are predicted to accrue in part
from diet-induced reductions in adiposity. However, the
extent to which increased EE and reductions in adiposity
are required for diet-induced improvements in insulin
sensitivity are not known.
Dietary MR increases EE soon after its introduction by
mimicking many of the responses observed during ther-
moregulatory thermogenesis. For example, dietary MR
produces a rapid increase in Ucp1 (uncoupling protein 1)
mRNA and protein expression in brown adipose tissue
(BAT) while simultaneously remodeling the morphology
of white adipose tissue (WAT) (1, 2). Although the mag-
nitude of these changes is depot specific, their overall im-
pact on thermogenic activity is most evident at night, when
a2-foldhigherheat increment of feeding is observed in the
MR group (2). This amplified increase in core tempera-
ture is temporally linked to an exaggerated increase in
nocturnal EE, suggesting that induction and activation of
UCP1 plays a key role inmediating the effects ofMRonEE
(2). In addition, the increase in EE and induction of Ucp1
expression by MR are dependent on b-adrenergic signal-
ing (7), consistent with a mechanism involving diet-
induced activation of the sympathetic nervous system
(SNS). Together, these findings make a compelling case
that dietary MR regulates the induction and activation of
UCP1 by increasing SNS activity, but a key remaining
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question is whether these changes in UCP1 are essential to
the diet-induced increase in EE.
Mice lacking Ucp1 are able to engage alternative ther-
mogenic mechanisms when cold stressed (8–10) but are
also differentially responsive to changes in housing tem-
perature in the sense that they are more prone to de-
veloping obesity thanwild-type (WT)mice when housed at
thermoneutrality but not standard housing temperatures
(22–23°C) (11). It is well established that rearing mice
under standard housing temperatures produces signifi-
cant activation of nonshivering thermogenesis through
SNS-dependent norepinephrine turnover in BAT and
WAT (12–15). The increased energy required to defend
body temperature and weight at 23°C is provided by
a commensurate increase in energy intake and EE
(15–17).Given that dietaryMRmay also utilize the SNS as
a motor arm to increase EE at 23°C, the strategy of the
presentworkwas to incorporateUcp1 loss of function into
an experimental design that also modulates SNS activity
by varying housing temperature. Using Ucp12/2 mice
housed at temperatures that either stimulate (23°C) or
minimize (28°C) SNS activity, we report here that dietary
MR increases EE and reduces fat deposition under both
conditions and requires UCP1 to do so. In contrast, diet-
induced enhancement of in vivo insulin sensitivity is fully
intact in the absence of UCP1.
MATERIALS AND METHODS
Animals and diets
All vertebrate animal experiments were reviewed and approved
by the Pennington InstitutionalAnimal Care andUseCommittee
using guidelines established by the National Research Council,
theAnimalWelfare Act, and the PHS Policy on humane care and
use of laboratory animals. The animals used in all experiments
were male C57BL/6J mice obtained from Jackson Labs (Bar
Harbor, ME, USA) at 4 weeks of age or age-matched male
C57BL/6J Ucp12/2 from our breeding colony. All mice were
adapted to the control diet for 7days before assignment to dietary
groups in each study. The feeding paradigm and diets were as
described previously (7), with the control diet containing 0.86%
methionine and the MR diet containing 0.17%methionine. The
diets were formulated as extruded pellets and the energy content
of both control andMRdiets was 15.96kJ/g, with 18.9%of energy
coming from fat (corn oil), 64.9%carbohydrate, and 14.8% from
a custommixtureof L-aminoacids. Diets andwater wereprovided
ad libitum, and lights were on from 7 AM to 7 PM. Housing tem-
peratures were either 23°C or 28°C as described for specific
experiments below.
Experiment 1
Age-matched wild-type (WT; e.g., Ucp1+/+) and Ucp12/2 mice
adapted to the control diet were randomly assigned in equal
numbers to housing temperatures of 23°C or 28°C. After adap-
tion to the respective housing temperatures for 1 week, half the
mice of each genotype were randomly assigned to receive theMR
diet while the remaining mice continued to receive the control
diet. The 2 housing temperatures were employed to evaluate the
effects of each diet on each genotype under conditions designed
to produce mild cold stress (23°C) or conditions near thermo-
neutrality (28°C) to minimize SNS activity (18). All mice were
singly housed in shoebox cages with corncob bedding, and
12 mice per genotype were assigned to the 4 groups as follows:
control diet at 23°C, control diet at 28°C,MR diet at 23°C, or MR
diet at 28°C. The mice received their diets for 11 weeks, after
which 4 mice from each genotype3 diet3 temperature combi-
nationwereanesthetizedandperfusedwith10%neutral buffered
formalin. Tissues from these mice were processed, embedded in
paraffin, and used for histologic analysis. Tissues and serumwere
collected from the remainingmice (n = 7–8) in each genotype3
diet3 temperature combination.
Indirect calorimetry
EE was measured after mice (n = 7–8 from each genotype 3
diet 3 temperature combination) had been on the respective
diets for 8 weeks using a Comprehensive Laboratory Animal
Monitoring System (Columbus Instruments, Columbus, OH,
USA). Power analyses suggested that 8 subjects would be required
for these studies, as determined using the variance inour primary
variables of interest at an effect size of 0.8 and an a level of 0.05.
Power calculations were determined using SAS for Windows
software (version 9.1; SAS Institute, Cary, NC, USA). The animal
numbers suggestedby thepower analysis tobeused ineachgroup
also coincides with our experience for the detection of differ-
ences in themajority of variables we would be interested in. It has
been suggested that additional replication is requiredwhenusing
ANCOVA, particularly when comparing animals of similar size
and composition (19). However, it was also noted that small
sample size is not a valid reason to avoid ANCOVA, because if the
study is insufficiently powered to detect treatment differences
with ANCOVA, it will also be underpowered for analyses by other
statistical approaches (20).
Body composition of each mouse was measured by NMR be-
fore entry anduponexit fromthemetabolic chambers.Micewere
acclimated in the metabolic chambers for 24 hours before con-
tinuousmeasurementofO2 consumption(VO2),CO2production
(VCO2), energy intake, andvoluntaryactivity at 16minute intervals
for 72 hours. EE was calculated as {VO2 3 [3.815 + (1.232 3
respiratory exchange ratio)]3 4.019}, while respiratory exchange
ratios were calculated as the ratio of VCO2 produced to VO2 con-
sumed. Group differences in EE (kJ/mouse/h) were compared
by ANCOVA (JMP Statistical Software, version 11; SAS Institute),
calculating least squares means that account for variation in EE
attributable to differences in lean mass, fat mass, activity, and
energy intake among themice. The least squaresmeans6 SEM for
each genotype, diet, and temperature were compared by 3-way
analysis of variance, and the significanceof themodel effects were
compared by residual variance within ANCOVA.
Experiment 2
The second experiment used hyperinsulinemic–euglycemic
clamps conducted on cohorts of WT and Ucp12/2mice (n = 6–9
from each genotype 3 diet combination) by the Vanderbilt
Mouse Metabolic Phenotyping Center (MMPC, Nashville, TN,
USA). WT and Ucp12/2 mice were shipped to the Vanderbilt
facility at 4 weeks of age. The animals were adapted to the control
diet for 1wk, then randomly assigned to receive either the control
or MR diet for a period of 9 weeks before the clamp procedure.
Animals were provided the diets and water ad libitum and housed
at standard roomtemperatureof (23°C)ona12h light cycle.One
week before the clamp procedure, catheters were surgically
placed in the carotid artery and jugular vein for sampling and
infusions, respectively.Micewerewithheld food for 5hours before
conducting the clamp procedure, as described previously (21).
Erythrocytes were replaced to prevent a decline in hematocrit
that occurs with repeated blood sampling. A primed (1.5 mCi)
continuous (0.075 mCi/min) [3-3H]glucose infusion was started
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at220 min. The clamp was initiated at 0 min with a continuous
insulin infusion (2.5 mU/kg/min) that was maintained for
145min.Arterial glucosewasmeasuredat10min intervals toprovide
feedback to adjust the glucose infusion rate (GIR) containing
[3-3H]glucose as needed to clamp glucose concentration and spe-
cific activity. [3-3H]Glucose kinetics were determined at 210 min
and at 10 min intervals between 80 and 120 min because insulin
action is in a steady state by this interval. Plasma insulin was
measured at 210 min, 100 min, and 120 min during the pro-
cedure. A 13 mCi intravenous bolus of 2[14C]deoxyglucose was
administered at 120 min and used to determine the glucose
metabolic index (Rg), an indication of tissue-specific glucose
uptake. Blood samples were collected at 2, 5, 10, and 25min after
injection tomeasure disappearance of 2[14C]deoxyglucose from
plasma. Tissues were collected to assess tissue specific Rg. Whole-
body glucose appearance and endogenous glucose production
(endo Ra), a measure of hepatic glucose production, were cal-
culated as previously described (21, 22).
Immunoblotting of UCP1
Mitochondrial extracts were prepared from BAT homogenates,
and tissue lysates were prepared from inguinal white adipose tis-
sue (IWAT). UCP1 expression was determined by Western blot
analysis using an affinity-purified antibody raised against the
peptide sequence corresponding to amino acids 145 to 159 in
mouse UCP1 (23). The respective blots for UCP1 in BAT and
IWAT were reprobed for PDC-E2 (BAT) and b-actin (IWAT) as
loading controls for the respective tissues. Detectedproteins were
quantitated using scanning laser densitometry and the relative
expression of UCP1 versus the corresponding loading control for
each tissue was calculated to test for diet-induced differences in
expression at each rearing temperature.Theb-actin antibodywas
from Sigma-Aldrich (St. Louis, MO, USA), and the PDC-E2 anti-
body was from Santa Cruz Biotechnology (Dallas, TX, USA).
RNA isolation and quantitative real-time PCR
Total RNA was isolated using an RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). One microgram of total RNA was reverse
transcribed to produce complementary DNA. Gene expression
was measured by RT-PCR (Applied Biosystems, Foster City, CA,
USA) by measurement of SYBR Green. mRNA concentrations
were normalized to cyclophilin expression.
Histology
Paraffin-embedded tissues from experiment 1 were sectioned at
5 mm and stained with hematoxylin and eosin (H&E). For adipo-
cyte size measurements, H&E-stained slides were scanned on
aHamamatsu NanoZoomer, and the resulting image files (NDPI)
were converted to equivalent 35 magnification JPEG files using
a conversion algorithm (http://www.matthias-baldauf.at/software/
ndpi-converter/). The JPEG images were then batch processed
within Fiji, an open-source platform for biologic image analysis
(24), using minimal image processing before thresholding and
subsequent identification/measurement of adipocytes using the
“Analyze Particles” plug-in with fixed size/shape cutoffs. The soft-
ware counted and measured all spherical cells on each slide from
size 200 to 50,000 mm2. On average, over 32,000 adipocytes were
counted and measured for each slide, with 2 slides per animal
analyzed and 4 animals per treatment group.
To assess the extent of “browning” within IWAT, paraffin-
embedded sections were dewaxed before heat-induced epitope
retrieval in apressurecooker for20minat100°C in sodiumcitrate
buffer (pH 6.0). Slides were blocked with normal goat serum
(5%) in Tris-buffered saline and Tween-20 (TBST) buffer for
1hourbefore incubationovernightwith rabbit anti-perilipin (Cell
Signaling Technology, Danvers, MA, USA). After washing in
TBST and incubation with an Alexa Fluor–conjugated goat anti-
rabbit secondary (Invitrogen, Carlsbad, CA, USA) for 1 hour, the
slides were incubated with WGA-Oregon Green (20 mg/ml) and
DAPI (500 nM) for 15 min. After washing briefly in TBST, the
slides were mounted with aquamount (Thermo Fisher Scientific,
Waltham,MA,USA) and subsequently scanned on aHamamatsu
NanoZoomer in fluorescence mode (DAPI/FITC/TxRed triple
cube). The resulting images were cropped andexported as JPEGs
at 35 or 310 resolution for analysis in Cell Profiler (http://www.
cellprofiler.org/citations.shtml). Briefly, a pipeline was generated to
identify cells containing both a green (cell membrane) and red
component (perilipin), as nonadipocytes would lack an obvious
perilipin signal. “Brownlike” cells were identified as those adipo-
cytes that, in addition to the peripheral green ring of WGA in
membranes, alsohadacritical level ofperilipin stainingwithin the
cells that is characteristic of multilocular adipocytes.
Metabolomics analysis
A portion of inguinal WAT from control and Ucp12/2 mice
housed at 23°C and fed the respective control and MR diets was
sent toMetabolon (Durham,NC,USA) formetabolomicsanalysis
using gas chromatography–mass spectrometry and ultra-
performance liquid chromatography–tandem mass spectrome-
try analytical platforms. Nonesterified fatty acids were extracted
from the adipose tissue without saponification using a methanol
extraction solution. The quality control analysis included several
technical replicate samples that were created from a homoge-
neous pool containing a small amount of all study samples. In-
strument and process variability met Metabolon’s acceptance
criteria, and a total of 257 metabolites were detected and quan-
tified in the inguinal WAT samples. Metabolites associated with
mediumchain, long chain, branched chain, andpolyunsaturated
fatty acids were analyzed by a 2-way ANOVA to test for effects of
genotype, diet, and genotype by diet interaction. Group means
were compared using residual variance as the error term.
Serum analysis
Blood glucose concentrations were measured via tail nick fol-
lowing a 6-hour food withdrawal through use of a OneTouch
UltraSmart glucometer. All other serum measurements were
determinedafter a4-hour foodwithdrawaluponcompletionof the
study. Serum insulin and fibroblast growth factor 21 (FGF21)
concentrations were measured with ELISA (Millipore, Billerica,
MA,USA, andR&DSystems,Minneapolis,MN,USA, respectively).
Statistical analysis
Response variables in experiment 1 were analyzed by a 3-way
ANOVA, with genotype, diet, and housing temperature as main
effects. The analysis tested for genotype 3 diet, genotype 3
temperature, diet 3 temperature, and genotype 3 diet 3 tem-
perature interactions using residual variance as the error term.
Body weight, adiposity, energy intake, cell sizing data, cellular
“browning” data, gene expression data, and the insulin clamp
data were compared within each housing temperature using a 2-
way ANOVA, and least squares means of each variable were
compared using residual variance as the error term and making
the Bonferroni correction. For metabolomics analysis, the data
for each identifiedmetabolite was analyzed using a 2-wayANOVA
to test for effects of genotype, diet, and any genotype 3 diet
interaction.Groupdifferences inmetabolite concentrationswere
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then assessed relative to all other groups following log trans-
formation and imputation of missing values, if any, with the
minimumobserved value for each compound. Protection against
type I errorswas set at 5%.GraphPadPrism software(La Jolla,CA,
USA) was used to generate figures.
RESULTS
Effects of housing temperature and dietary MR on
energy balance
To assess the role of UCP1 as a mediator of the effects of
dietary MR on energy balance, EE was measured by in-
direct calorimetry in cohorts of WT and Ucp12/2 mice
housed under standard conditions (e.g., 23°C) or within
the thermoneutral zone at 28°C (17, 18). This approach
was taken to deconflate the effects of dietary MR on EE
from the effects of rearing temperature on EE and test
whether induction and activation of UCP1 is essential to
the ability of dietaryMR to increase EE.ANCOVAwas used
to assess the impact of genotype, diet, and temperature on
EE after adjusting for variation in total EE associated with
variation in activity, lean mass, fat mass, and food intake of
mice within each group. The relative contributions of
model components in accounting for variation in total EE
is shown as the t ratio of each variable’s impact on EE (Fig.
1). Although allmodel effects were significant, Fig. 1 shows
that activity was a significant contributor to variation in EE
among the mice. However, activity did not differ between
the genotypes at either housing temperature or on either
diet (Table 1), indicating that it is not the basis for either
genotypic or diet-induced differences in EE. Temperature
had a significant independent effect on EE such that irre-
spective of genotype,EE inmiceon the control diet at 23°C
was 30% to 40%higher than EE inmice at 28°C.Genotype
and diet also had significant independent effects on EE
(Fig. 1), and a significant genotype3 diet interaction was
detected based on the differential effects of dietary MR on
EE in each genotype. For example, dietary MR produced
a comparable 30% increase in EE in WT mice at both
housing temperatures, while the diet had no effect on EE
in Ucp12/2 mice at either temperature (Table 1).
The effect of temperature on energy intake in mice on
the control dietwas comparable betweenWTandUcp12/2
mice because irrespective of genotype, mice housed at
23°C consumed 25% to 30%more food thanmice housed
at 28°C (Table 1). In contrast, the effect of diet on energy
intake differed between the genotypes, creating a signifi-
cant genotype 3 diet interaction. For example, WT mice
on theMRdiet increased energy intake by 16%and18%at
23°C and 28°C, respectively, while Ucp12/2 mice on the
MR diet reduced their energy intake by 36% at 23°C and
57% at 28°C (Table 1).
The combined effects of dietary MR on energy intake
and expenditure at the 2 housing temperatures affected
energy balance in WT mice in the predicted manner. For
example, the diet-induced increase in EE in WT mice at
both temperatures was larger than the corresponding diet-
induced increases in energy intake. This translated into
significant diet-induced reductions in accumulation of
body weight and adiposity at both temperatures (Table 1).
In contrast, thepredominant effect ofdietaryMR inUcp12/2
mice was to reduce energy intake without affecting EE.
Despite the resulting negative energy balance, the Ucp12/2
mice on the MR diet had a surprising expansion (23°C) or
retention (28°C) of adiposity at the 2 temperatures
(Table 1). The Ucp12/2 mice consuming the MR diet
gained little to no weight at either temperature over the
course of the study, but when energy intake is expressed
per unit body weight, weight-adjusted energy intake was
the same as Ucp12/2 mice on the control diet (Table 1).
This further supports the conclusion that dietaryMRhad
no effect on EE in Ucp12/2 mice and affected energy bal-
ance solely through effects on energy intake. Collectively,
these findings show that UCP1 is essential to the ability of
dietaryMR to increase EE, and rather than increase energy
intake as expected, the absence of Ucp1 results in a para-
doxical reduction in consumption of the diet.
Effects of housing temperature on UCP1 expression
by dietary MR
It is well established that mice reared at 22°C to 23°C ex-
perience significant cold stress and increase SNS-
dependent browning of WAT and expression of UCP1 in
BAT to defend body temperature by adaptive thermo-
genesis (15, 17, 18, 25). Given that dietaryMR is thought to
use the SNS to increase UCP1 and EE through similar
mechanisms (7), and that mice lacking Ucp1may be more
sensitive to thermal stress than WT mice (18, 25), the
effects of genotype, diet, and housing temperature on
thermogenic capacity were evaluated in BAT and WAT
from the respective animals. In WT mice housed at 23°C,
dietary MR produced a significant increase inUcp1mRNA
and protein expression in both BAT (Figs. 2A, B) and
IWAT (Figs. 2C, D). Compared tomice on the control diet
at 23°C, housing at 28°C produced a significant reduction
in Ucp1mRNA in both BAT (Fig. 2A) and IWAT (Fig. 2C).
A corresponding temperature-dependent decrease in
UCP1protein in the2 tissueswasnotdetected.However, in
both BAT and IWAT from mice housed at 28°C, dietary
MR produced a significant increase in Ucp1 mRNA and
protein compared tocontrols (Fig. 2A–D).Together, these
findings indicate that the effects of housing temperature
and dietary MR on UCP1 expression are independent.
Figure 1. Assessment of components contributing to variation
in EE. The relative contributions of model components in
accounting for variation in total EE is shown as the t ratio of
each variable’s impact on EE. EE was measured in mice
(n = 7–8) by indirect calorimetry after consuming control
(CON) or MR diets for 8 wk at 23°C or 28°C.
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Thus, although temperature plays an important role in
matching UCP1 expression to environmental conditions,
dietary MR retains the ability to independently increase
UCP1 expression under both conditions.
Effects of UCP1 and housing temperature on
remodeling of WAT
Mice lacking Ucp1 are able to engage alternative thermo-
genic mechanisms to defend body temperature when
gradually adapted to cold (9, 25), but the extent to which
standard housing conditions, relative to thermoneutrality,
provoke adaptive changes in SNS-dependent activity and
adipose tissue remodeling isunclear.Given thepotential of
SNS-dependent remodeling of adipose tissue to affect EE
and glucose utilization, even in the absence of UCP1 (26),
remodeling of adipose tissue by dietary MR was evaluated
in WT and Ucp12/2 mice housed at 23°C and 28°C. Rep-
resentative H&E stained sections of IWAT from each ge-
notype, diet, and housing temperature are shown in Fig.
3A. Unbiased analysis of cell size illustrates a genotype 3
diet interaction at both temperatures (Fig. 3B). For ex-
ample, dietary MR increased the number of small adipo-
cytes in WT but not Ucp12/2 mice housed at 23°C, but at
28°C,dietaryMRincreased thenumberof small adipocytes
in Ucp12/2 mice but not WT mice (Fig. 3B). In MR-fed
Ucp12/2 mice at 28°C, this was complemented by a corre-
sponding decrease in intermediate size adipocytes (Fig.
3B). Perhaps most interesting was the genotype 3 diet
interaction at 23°C, where the number of small adipocytes
inUcp12/2mice on the control diet wasmuchhigher than
the number inWTmice (Fig. 3). DietaryMR produced no
additional effects on cell size in Ucp12/2 mice housed at
23°C. These data suggest that IWAT has undergone sig-
nificant remodeling in Ucp12/2 mice on control diet
housed at 23°C compared to WT mice. In addition, the
change in cell morphology between 28°C and 23°C is
much more evident in Ucp12/2 mice compared to WT
mice (Fig. 3A).
Remodeling of IWAT was evaluated using a second
imaging-based approach to detect changes in the number
of multilocular cells within the depot. Figure 4 shows that
dietary MR produced a significant 3-fold increase in the
percentage of multilocular adipocytes within IWAT of WT
mice at 23°C, but less than a 2-fold increase in WT mice
housed at 28°C. Ucp12/2mice on the control diet at 23°C
hada4-foldgreaterpercentageofmultilocularadipocytes in
IWAT compared to WT mice, and not surprisingly, dietary
MRproducedonly amodest further increase in remodeling
at this temperature (Fig. 4). Housing Ucp12/2mice on the
control diet at 28°C resulted in a reciprocal decrease in the
percentageofmultilocular adipocytes to levels similar toWT
mice housed at 23°C (Fig. 4). DietaryMRproduced a 3-fold
increase in percentage of multilocular adipocytes in IWAT
of Ucp12/2 mice at 28°C (Fig. 4).
Together, these data illustrate the involvement of
a complex but unexpected genotype 3 temperature in-
teraction in IWAT morphology. On the basis of the in-
volvement of FGF21 in remodeling of WAT (27–29) and





WT Ucp12/2 WT Ucp12/2
Control MR Control MR Control MR Control MR
Initial body
weight (g)
16.0 6 0.5a 15.9 6 0.5a 13.7 6 0.8a 13.5 6 0.7a 15.9 6 0.5a 15.9 6 0.5a 13.6 6 0.6a 13.7 6 0.7a
Final body
weight (g)
26.1 6 1.2a 22.8 6 0.5b 21.3 6 0.5a 15.5 6 0.8b 25.9 6 0.4a 21.5 6 0.3b 24.0 6 0.5a 13.6 6 0.6b
Initial %
adiposity
15.6 6 0.5a 16.0 6 0.6a 20.8 6 0.9b 20.1 6 0.7b 15.6 6 0.5a 16.1 6 0.4a 20.1 6 0.9b 19.4 6 1.0b
Final %
adiposity
18.4 6 1.3a 13.9 6 0.7b 18.0 6 0.5a 23.3 6 0.9b 16.0 6 0.4a 13.6 6 0.7a 19.6 6 0.6b 20.4 6 1.0b
Energy intake
(kJ/d/mouse)
41.0 6 0.5a 47.7 6 0.6b 36.9 6 0.6c 27.1 6 0.8d 31.0 6 0.3c 36.6 6 1.1c 29.8 6 0.3c 19.0 6 0.5d
Energy intake
(kJ/d/g)




1.66 6 0.02a 2.17 6 0.01b 1.68 6 0.01a 1.67 6 0.01a 1.02 6 0.01c 1.31 6 0.01d 1.16 6 0.01e 1.21 6 0.02e
Total activity 621 6 50a 621 6 33a 536 6 49a 440 6 68a 629 6 46a 661 6 34a 577 6 34a 448 6 62a
Energy expenditure was measured 8 weeks after initiating diets using indirect calorimetry and analyzed by analysis of covariance as described
in the Materials and Methods using genotype, housing temperature, and diet as main effects and calculating least squares means using lean mass,
fat mass, and activity as covariates. Body weight, adiposity, energy intake, and total activity were compared using a 3-way ANOVAs using genotype,
housing temperature, and diet as main effects and testing for interactions. Least squares means were compared using residual variance as
the error term and presented as means 6 SEM (n = 8–9/group). Means denoted with different superscripts (a–d) within housing temperatures
differ at P, 0.05. Body composition was measured by NMR as described in the Materials and Methods, and percentage adiposity was calculated as
[(fat mass/body weight)3 100]. The average food intake less spillage was determined over a 24-hour period each week in mice of each genotype
on each diet and at each housing temperature, converted to kilojoules, and expressed per mouse or per unit of body weight. Means represent
average daily energy intake over the entire study and were compared as described above.
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thedemonstrationof its regulationbydietaryMR(6),Fgf21
expression was evaluated to test for a potential role in this
interaction.Figure5 shows that inmiceonboth the control
andMRdiets, hepatic Fgf21mRNAand serumFGF21 levels
were significantly higher inUcp12/2 thanWTmice at both
housing temperatures.DietaryMRalsoproducedagreater
absolute increase in serum FGF21 levels in Ucp12/2 mice
compared to WT mice, but the fold increase in serum
FGF21 produced by MR was comparable between the
genotypes at both temperatures (Fig. 5B). Although not
significant, there was a strong suggestion of a temperature-
dependent increase in both hepatic mRNA and serum
FGF21 inWTmice between 23°C and 28°C, irrespective of
diet (Fig. 5). In contrast, temperature had no effect on
serum FGF21 levels of Ucp12/2mice on either diet. These
data are suggestive of a potential role for FGF21 in the
exaggerated remodelingof IWAT inUcp12/2micehoused
at 23°C, although the reversion of adipocyte morphology
to a more unilocular phenotype when these mice were
housed at 28°C, despite their elevated FGF21, may be in-
dicative of a requirement for coincident SNS input. The
intense remodeling of IWAT by MR in Ucp12/2 mice at
28°C is consistent with this suggestion, although future
studies will be required to address this possibility in detail.
Effects of genotype and diet-dependent remodeling
of WAT on fatty acid composition
To assess the impact of genotype- and diet-dependent
remodeling of IWAT on lipid composition at 23°C,
targeted analysis of medium chain, long chain, branched
chain, and polyunsaturated nonesterifed fatty acids was
conducted in this depot. Figure 6 shows a heatmap of the
genotype- and diet-dependent effects on each metabolite,
along with tests for main effect interactions. The highly
significantdegreeof remodelingof IWATnoted inUcp12/2
mice on the control diet compared to WT mice (Figs. 3
and4) ismirroredby significant increases in 2of 4medium
chain fatty acids, 12 of 15 long chain fatty acids, 6 of 11
polyunsaturated fatty acids, and 1 of 2 branched chain fatty
acids in this group. In contrast, dietary MR produced
essentially no further increase in remodeling of IWAT
in Ucp12/2 mice (Fig. 4B) or in fatty acid metabolites
(Fig. 6). The most profound impact on fatty acid metabo-
lism was seen inWTmice on theMRdiet compared to the
control diet, where only 6 of 32 metabolites were un-
affected by the diet (Fig. 6). In this comparison, it is par-
ticularly noteworthy that every long chain fatty acid in our
profile was significantly increased by dietary MR (Fig. 6).
The increase in free fatty acid content of the IWATmay be
indicative of increased lipolysis. We have previously shown
that MR increases fatty acid oxidation in IWAT (1). We
would also expect increased de novo lipogenesis, which
occurs at a higher rate in beige adipocytes compared to
white (30), but given that lipid synthesis and metabolism
are constantly cycling, these data provide a snapshot of the
alteration in lipid metabolism induced by theMR diet and
genetic deletionofUcp1.Overall, these data provide strong
evidence that the genotypic and dietary effects on remod-
eling of IWAT resulted in profound changes in fatty acid
metabolism within this depot.
Figure 2. Effect of diet and housing temperature on UCP1 expression. Ucp1 gene and protein expression in BAT (A and B,
respectively) and IWAT (C and D, respectively) from WT mice fed the control (CON) or MR diets housed at either 23°C or 28°C for
11 weeks. mRNA expression was normalized to cyclophilin. Relative band densities of UCP1 protein expression were normalized to
PDC-E2 (BAT) or b-actin (IWAT). Means 6 SEM are presented. Different letters denote statistically significant differences.
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Effects of temperature, genotype, and diet on fasting
insulin and glucose
In mice housed at 23°C, there were no meaningful differ-
ences in fasting glucose among the groups, although
a clear suggestion of a glucose lowering effect of MR in
both genotypes was evident (Table 2). Both glucose and
fasting insulin were lower in Ucp12/2 mice on the control
diet compared to WT mice on the same diet (Table 2).
Dietary MR reduced fasting insulin in both genotypes, but
only the decrease in WT mice reached statistical signifi-
cance.Housingat 28°Cversus23°Chadessentiallynoeffect
on fasting insulin in WT mice on the control diet and no
effect on the ability of MR to reduce insulin levels in this
genotype (Table 2). In contrast, housingUcp12/2mice on
the control diet at 28°C increased fasting insulin to levels
observed in WT mice at 23°C (Table 3). Despite this in-
crease, MR reduced fasting insulin by 4-fold in Ucp12/2
mice housed at 28°C (Table 2).
Effects of genotype and diet on in vivo
insulin sensitivity
To assess the effects of genotype and dietaryMR on insulin
sensitivity in mice housed at 23°C, hyperinsulinemic–
euglycemic clamps were employed after mice received the
control or MR diets for 8 weeks. The GIRs needed to es-
tablish euglycemia after initiationof insulin infusion at time
0wereachievedwithin40minutes inall 4 treatmentgroups,
and steady-state glucose levels were maintained during the
final hour of the clamp across the groups (Fig. 7A). The
GIRs needed to establish steady-state glucose levels were
essentially identical in WT and Ucp12/2 mice on the con-
trol diet (Fig. 7A), despite the significantly lower fasting
insulin levels detected in Ucp12/2mice on the control diet
at 23°C (Table 2). The steady-stateGIRneeded tomaintain
euglycemia was 2.2-fold higher in mice on the MR diet,
regardless of genotype (Fig. 7A). Thus, the absence ofUcp1
affected neither overall insulin sensitivity nor the ability of
Figure 3. Effect of genotype, diet, and housing temperature on adipose tissue morphology. A) Representative H&E stains of
IWAT from WT and Ucp12/2 mice fed the control (CON) or MR diets housed at either 23°C or 28°C for 11 weeks. Scale bars,
400 mm. B) Adipocyte sizes (area per adipocyte, mm2) in control (CON) or MR-fed WT and Ucp12/2 mice graphed as percent of
total adipocytes. X axis indicates bin center with bin sizes of 1000. Means 6 SEM are presented for each variable and are based on
n = 4 per group. Different letters denote statistically significant differences within each adipocyte size bin.
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the mice to increase sensitivity in response to dietary MR.
However, further evaluation of tissue-specific responses to
insulin revealed several significant differences between
genotypes. Liver glucose metabolism was assessed using 3-
[3H]-glucose infusion to calculate basal endo Ra and com-
pare insulin-dependent suppression of endo Ra during the
hyperinsulinemic–euglycemic clamp. Suppression of he-
patic glucose production by insulin was comparable in WT
and Ucp12/2 mice on the control diet, and MR enhanced
theefficacyof insulin to suppresshepaticglucoseproduction
in both genotypes (Fig. 7B). The Rg provides a direct mea-
sure of insulin sensitivity in each tissue, and it showed that
MR produced significant increases in uptake of [14C]2-
deoxyglucose (2-DG) in gastrocnemius muscle (2.6-fold),
vastus lateralis muscle (3.1-fold), epididymal white adipose
tissue (3.6-fold), IWAT (8.3-fold), BAT (1.5-fold), and heart
(2-fold) of WTmice (Fig. 7C, D). The responses of Ucp12/2
mice toMRwere similar inmany respects but fundamentally
different in others. For example, MR increased Rg in gas-
trocnemius muscle and epididymal white adipose tissue to
the same degree in Ucp12/2 and WT mice, while in vastus
lateralis, IWAT, BAT, andheart, the effect ofMR inUcp12/2
mice did not reach significance (Fig. 7C, D). Particularly
noteworthy was the diet-independent effect of genotype on
Rg in IWAT, where insulin-dependent [
14C]2-DG uptake in
Ucp12/2 mice on the control diet was 19-fold higher than
uptake in WT controls (Fig. 1C). Therefore, it is not sur-
prising that dietary MR produced no further increase in in-
sulin sensitivity here. In other tissues inUcp12/2mice where
MR failed to increase Rg, there was a noticeable effect of
genotype on [14C]2-DG uptake that was not attributable to
diet (Fig. 7C, D). These tissue-specific differences notwith-
standing, overall insulin sensitivity was comparable between
genotypes, and dietary MR produced an almost identical
increase in insulin-dependent GIR between the genotypes.
DISCUSSION
Previous studies establish that dietary MR produces a co-
ordinated series of biochemical and physiologic responses
Figure 4. Effect of genotype, diet, and housing temperature on browning of WAT. A) Representative images of IWAT from WT
and Ucp12/2 mice fed the control (CON) or MR diets housed at either 23°C or 28°C for 11 weeks. Scale bars, 400 mm. Cell
membranes were stained with wheat germ agglutinin (green), lipid droplet membranes were stained with perilipin (red), and
nuclei were stained with DAPI (blue). B) Relative number of multilocular, brownlike adipocytes graphed as percentage of total
adipocytes. Means 6 SEM are presented for each variable and are based on n = 4 per group. Different letters denote statistically
significant differences within each housing temperature.
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that develop soon after introduction of the diet and persist
for as long as the diet is consumed (3, 7, 31–34). The bi-
ologic significance of these effects in aggregate is sub-
stantial, resulting in animals that are leaner, that are more
insulin sensitive, and that live longer (1, 2, 35–37). An im-
portant unresolved question is whether the effects of di-
etary MR on overall insulin sensitivity are the result of and
dependent on the effects of thediet on energybalance and
adiposity. Thepresentwork sought to address this question
while also assessing the importance of UCP1 in the mech-
anistic effects of theMRdiet onEE.Using an experimental
approach designed to separate environmental and dietary
inputs to transcriptional regulation of Ucp1, the most sig-
nificant findings of this work are that UCP1 is essential to
the ability of dietaryMR to increase EE but not to its ability
to increase insulin sensitivity. A potential caveat is that en-
ergy intake was unexpectedly decreased by dietary MR in
Ucp12/2 mice opposite from the hyperphagic response
normally produced by the diet (7). Thus, even in the ab-
sence of a dietary effect on EE in Ucp12/2 mice, the re-
duction in energy intake was sufficient to limit growth.
More surprisingly, despite near cessation of growth in
Ucp12/2mice on theMRdiet, fat depositionwas preserved
at the expense of lean tissue. By study’s end, this un-
expected pattern of nutrient partitioning resulted in
Ucp12/2 mice that were significantly smaller but had
greater adiposity than WT mice on the MR diet. Despite
these differences in body composition, we found no evi-
dence that dietary MR affected EE in Ucp12/2 mice at
either housing temperature. This is fully consistent with
our data showing that decreased body weight inUcp12/2
mice on the MR diet was fully accounted for by the ob-
served reductions in energy intake.Thesefindings point to
an unexpected role forUCP1 in the hyperphagic response
to dietary MR. One possibility is that the hyperphagic re-
sponse is compensatory and the result of the UCP1-
dependent increase in EE. In such a scenario, the absence
of a diet-induced increase in EE in Ucp12/2 mice would
remove the signal for a compensatory increase in energy
intake.However, there isnodirectevidence to support such
a mechanism, and it remains unclear how the absence of
a diet-induced increase in EE could trigger the observed
negative effect on energy intake. Alternatively, recent work
suggests thatUCP1 is involved in the anorexigenic effects of
leptin (38) basedonfindings that exogenous leptinwas less
able to reduce food intake in Ucp12/2 compared to WT
mice. Previousworkhas shown that dietaryMR significantly
lowers circulating leptin by reducing its expression in adi-
pose tissue (2), but dietary MR did not lower leptin mRNA
in BAT or IWAT of Ucp12/2 mice here (data not shown).
This finding notwithstanding, the observed negative effect
of the diet on energy intake suggests the involvement of an
additional mechanism beyond the absence of the normal
hyperphagic leptin signal generated by MR in WT mice.
Mice perceive mild cold stress at normal housing tem-
peratures (e.g., 23°C) and respond by increasing UCP1-
dependent thermogenesis in BAT and WAT (15, 17). The
associated expansionof thermogenic capacity in each site is
regulated by norepinephrine from sympathetic nerves in-
nervating the respective fat depots. The intensity of SNS-
dependent recruitment andactivationofUCP1 inBATand
WAT is regulated along a thermal continuum, with mice
housed in the thermoneutral zone (28°C to 36°C) having
little need to activate thermogenesis, while housing at 4°C
requires maximal recruitment and mobilization of ther-
mogenic capacity for survival (18, 25). As recently noted by
Nedergaard and Cannon (15), changes in the integrity of
an animal’s insulation (e.g., hair, skin) can enhance heat
loss at temperatures below thermoneutrality, amplifying
the perception of cold and necessitating a greater than
normal thermogenic response to defend body tempera-
ture.This raises thequestionofwhether the absenceof the
critical thermoregulatory molecule, UCP1, intensifies the
perception of cold in Ucp12/2 mice such that normal
housing temperatures produce a compensatory increase
in SNS stimulation of adipose tissue. Such a view is sup-
ported by the extensive remodeling observed in inguinal
WAT of Ucp12/2 mice housed at 23°C compared to WT
controls ((10) and this study). Additionally, the higher
FGF21 levels inUcp12/2mice at 23°Ccouldbeacting as an
endocrine enhancer of browning inWAT(28, 29). Recent
workproposes that FGF21also acts centrally to induceSNS
activity (39), providing a potential mechanism for FGF21
to act through a combinationofdirect effects onWATand
indirectly through centrally mediated SNS-dependent
recruitment of thermogenic activity. We recently pro-
posed that the MR-induced increase in hepatic Fgf21 ex-
pression serves as an endocrine signal linking the direct
effects of MR in the liver to increased insulin sensitivity
Figure 5. Effect of genotype, diet, and housing temperature
on FGF21. Hepatic Fgf21 mRNA expression (A) and serum
concentrations (B) from WT and Ucp12/2 mice fed the control
(CON) or MR diets housed at either 23°C or 28°C for 11 weeks.
mRNA expression was normalized to cyclophilin. Serum samples
were collected after a 4-hour food withdrawal. Means 6 SEM are
presented for each variable and based on n = 7–8 per group.
Different letters denote statistically significant differences.
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and glucose uptake in WAT (6). Thus, it seems possible
that FGF21 could be a critical link between MR’s effects
on adipose tissue remodeling and enhanced insulin
sensitivity.
The present findings make a compelling case that
housing temperature and dietary MR interact to produce
genotype-specific patterns of remodeling within the IWAT
depot. Housing Ucp12/2 mice at 23°C alone is sufficient
to produce extensive remodeling of the depot, leaving
little additional effect of dietary MR under these con-
ditions.HousingUcp12/2mice at 28°C causes a reversion
of adipocyte morphology to large unilocular cells, while
Figure 6. Group contrasts are represented as mean ratios, with red- and green-shaded cells indicating significant (P # 0.05)
increases (red) or decreases (green) in the mean ratios. Cells shaded with light red and light green indicate that the mean ratios
were trending (e.g., 0.05 , P , 0.10) higher (light red) or lower (light green) for that comparison. For ANOVA of main effects,
blue-shaded cells indicate P # 0.05, while light blue-shaded cells indicate 0.05 , P , 0.10.
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providing them the MR diet under these conditions
restores its efficacy to increase the number of small,
multilocular, beige/brown adipocytes within the depot.
An important question is the extent to which the remod-
eling impacts the observed metabolic phenotype within
the context of each genotype. Ex vivo and in vivo data from
IWAT in mice housed at 23°C imply that both genotype
and diet had significant effects on fatty acid metabolism
and glucose uptake under these conditions. For example,
in the highly remodeled IWAT from Ucp12/2mice on the
control diet, both insulin-dependent glucose uptake and
fatty acid metabolism were significantly enhanced com-
pared toWTcontrols. This is consistent with recent reports
that brownedWATdisplays enhancedbasal glucoseuptake
andhas altered lipidmetabolism (30, 40). Interestingly, no
additional effect of dietary MR on adipocyte morphology,
glucose uptake, or fatty acidmetabolismwas discernable in
Ucp12/2 mice housed at 23°C. The extensive remodeling
of IWAT in Ucp12/2 mice at 23°C may be the result of
a compensatory intensification of SNS activity, but the
unexpectedly higher FGF21 levels in thesemice could also
be a contributing factor. However, the failure of the ele-
vated FGF21 in Ucp12/2 mice housed at 28°C to effect
IWAT remodeling, coupled with the highly effective
remodelingproducedbydietaryMR in thesemice suggests
that SNSactivity is theprimary regulatorofbrowning in this
experimental context. Compared to Ucp12/2 mice, WT
mice at 23°C on the control diet showed little evidence of
TABLE 2. Fasting glucose and insulin concentrations in WT and Ucp12/2 mice housed at 23°C or 28°C and fed control or methionine-




WT Ucp12/2 WT Ucp12/2
Control MR Control MR Control MR Control MR
Glucose (mg/dl) 209 6 14b 189 6 7b,c 185 6 5b,c 160 6 11c 177 6 9b,c 166 6 14c 148 6 5c 90 6 10d
Insulin (ng/ml) 1.3 6 0.2b 0.37 6 0.1c 0.47 6 0.1c 0.26 6 0.1c 1.3 6 0.2b 0.42 6 0.1c 1.4 6 0.3b 0.31 6 0.1c
Blood glucose was measured after a 6-hour food withdrawal after 10 weeks on diet; serum insulin was measured after 11 weeks on diet after
a 4-hour food withdrawal. The serum parameters were compared by a 3-way analysis of variances using genotype, housing temperature, and diet
as main effects and testing for interactions. Least squares means were compared using residual variance as the error term and presented as
means 6 SEM (n = 8/group). Means denoted with different superscripts (a–d) differ at P , 0.05.
Figure 7. Hyperinsulinemic-euglycemic clamps in WT and Ucp12/2 mice housed at 23°C after 9 weeks of dietary MR. The clamp
procedures were conducted as described in the Materials and Methods. A) GIR required to maintain euglycemia during the
insulin clamps. B) The ability of insulin to suppress hepatic glucose production (% suppression of endo Ra) during the clamp
procedure. Different letters denote statistically significant differences. C) Rg, an indication of tissue-specific insulin-dependent
glucose uptake. Means6 SEM are presented for each variable and are based on n = 6–9 per group. *Means differ from mice of the
same genotype fed the control (CON) diet at P , 0.05.
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remodeling of IWAT, with adipocytes retaining a unilocu-
lar morphology. Dietary MR was highly effective in these
mice, increasing the number of small multilocular adipo-
cytes with increased thermogenic capacity, increased ca-
pacity to metabolize fatty acids, and enhanced capacity to
take up glucose. Considered together, the data provide
compelling evidence that the remodeling of IWAT by
dietary MR has a significant physiologic impact in each ge-
notype that contributes to the resulting metabolic
phenotype of the mice.
A key objective of the present studies was to determine
whether the ability of dietary MR to influence insulin
sensitivity was dependent on its ability to increase EE and
limit fat deposition. A loss of function approach showed
that UCP1 was essential to the ability of dietary MR to
increase EE but not to its ability to enhance insulin sensi-
tivity. That conclusion is supported by the identical
improvements in overall insulin sensitivity that were pro-
duced by dietary MR in WT and Ucp12/2 mice. In recent
work, we proposed that dietary MR enhances insulin sen-
sitivity through a combination of direct effects in the liver
to amplify insulin signaling and indirect effects in adipose
tissue through MR-dependent increases in hepatic tran-
scription and release of FGF21 (6). The diet-induced
increases in both basal and insulin-dependent glucose
uptake in isolated brown and white adipocytes (6) are
consistent with established effects of FGF21 on glucose
transport in human primary adipocytes (27). On the basis
of recent studies showing that FGF21 is also involved in
browning of WAT (28) while acting centrally to regulate
SNSactivity (39), thehigher levels of FGF21(basal andMR
induced) may be important to retention of the insulin
sensitizing effects of MR in Ucp12/2 mice. The greater
remodeling of IWAT in Ucp12/2 mice and the higher Rg
in this tissue are consistent with this suggestion. Although
the complex effects of Ucp1’s absence on temperature
sensitivity, SNS-dependent remodeling among fat depots,
andhepatic FGF21productionarepoorly understood, the
current results provide compelling evidence that the
ability of dietary MR to enhance in vivo insulin sensitivity
are not compromised by its absence.
The potential to translate the reported benefits of di-
etary MR from preclinical studies to the clinic was assessed
in an initial proof of concept study in subjects with meta-
bolic syndrome (41). The approach involved elimination
of meat, poultry, dairy, and grains from the diet and re-
placement of 100% of the daily protein requirement with
the commercial food,Hominex-2, a semisyntheticmixture
of L-amino acids low in cystine and lacking methionine.
Hominex-2 was developed for children with pyridoxine-
insensitive homocystinemia or hypermethionemia. The
poor palatability of Hominex-2 may have led to poor
compliance, because the reduction in plasma methionine
in the MR group was only 14% (41). This limitation not-
withstanding, dietary MR increased 24-hour fat oxidation
and reduced hepatic lipid content. Thus, preexisting
obesity and insulin resistancedidnotprevent subjects from
responding to the MR diet, although their responses were
clearly not as robust as observed in preclinical studies. We
believe that the presence of cysteine in Hominex-2 may
provide the key to the small reductions in plasma methio-
nine and modest physiologic responses to the diet. The
methionine-sparing effect of cysteine is well documented
(42), so the rodent MR diets are formulated without cys-
teine. Recent work has shown that adding back relatively
high amounts of cysteine (e.g., 0.5%) to the MR diet com-
pletely reversed its beneficial metabolic effects (43).
Moreover, recent unpublished studies in our lab found that
addingback as little as 0.2%cysteine to theMRdiet reversed
all but the direct transcriptional effects of MR on specific
hepatic genes associated with de novo lipogenesis (e.g.,
stearoyl-CoA desaturase-1). This could explain why the
presence of cysteine inHominex-2 limited the effects of the
diet to those on hepatic lipid metabolism (41). Viewed to-
gether, thesefindings argue that successful implementation
of dietary MR in a clinical setting would require both
restricting methionine to a specific range and eliminating
cysteine. Thus, the keys tousingMRas a dietary approach to
treat metabolic disease will involve developing palatable
foods thateliminatecysteineandprovidemethioninewithin
the defined range shown to be biologically effective.
The authors thank C. Tramonte for administrative support.
This work was supported in part by the American Diabetes
Association 1-12-BS-58 (T.W.G.), U.S. National Institutes of
Health (NIH) Grants DK096311 (to T.W.G.), DK098687 (to
R.L.M.), DK089641 (to R.L.M.), and the Mouse Metabolic
Phenotyping Center Consortium (NIH U24 DK059637). This
work also made use of the Genomics and Cell Biology and
Bioimaging core facilities supported by NIH P20 GM103528
(to T.W.G.) and NIH 2P30 DK072476. This research project
used the Transgenic and Animal Phenotyping core facilities
that are supported in part by the NIH Nutrition Obesity
Research Centers Grant 2P30 DK072476) (to R.L.M.). D.W.
is supported by NIH National Research Service Award 1 F32
DK098918. The authors thank M. Orgeron, K. Dille, and A. Pierse
for their technical support.
REFERENCES
1. Hasek, B. E., Boudreau, A., Shin, J., Feng, D., Hulver, M., Van,
N. T., Laque, A., Stewart, L. K., Stone, K. P., Wanders, D., Ghosh,
S., Pessin, J. E., and Gettys, T. W. (2013) Remodeling the
integration of lipid metabolism between liver and adipose tissue
by dietary methionine restriction in rats. Diabetes 62, 3362–3372
2. Hasek, B. E., Stewart, L. K., Henagan, T. M., Boudreau, A.,
Lenard, N. R., Black, C., Shin, J., Huypens, P., Malloy, V. L.,
Plaisance, E. P., Krajcik, R. A., Orentreich, N., and Gettys, T. W.
(2010) Dietary methionine restriction enhances metabolic
flexibility and increases uncoupled respiration in both fed and
fasted states. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299,
R728–R739
3. Malloy, V. L., Krajcik, R. A., Bailey, S. J., Hristopoulos, G.,
Plummer, J. D., and Orentreich, N. (2006) Methionine
restriction decreases visceral fat mass and preserves insulin
action in aging male Fischer 344 rats independent of energy
restriction. Aging Cell 5, 305–314
4. Munzberg, H., Henagan, T. M., and Gettys, T. W. (2013) Animal
models of obesity: perspectives on evolution of strategies for the
development and analysis of their phenotypes. In Handbook
of Obesity, (Bray, G.A. and Bouchard, C., eds.), pp. 137–148,
Informa Books, London
5. Blaxter, K. L. (1986) Bioenergetics and growth: the whole and
the parts. J. Anim. Sci. 63 (Suppl. 2), 1–10
6. Stone, K. P., Wanders, D., Orgeron, M., Cortez, C. C., and Gettys,
T. W. (2014) Mechanisms of increased in vivo insulin sensitivity
by dietary methionine restriction in mice. Diabetes 63, 3721–3733
7. Plaisance, E. P., Henagan, T. M., Echlin, H., Boudreau, A., Hill,
K. L., Lenard, N. R., Hasek, B. E., Orentreich, N., and Gettys,
T. W. (2010) Role of b-adrenergic receptors in the hyperphagic
and hypermetabolic responses to dietary methionine restriction.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R740–R750
2614 Vol. 29 June 2015 WANDERS ET AL.The FASEB Journal x www.fasebj.org
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